Jayant Prakash

Jayant Prakash

Auto-generated profile, based on publicly available information

Jayant Prakash

Department of Paediatrics, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2026 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
RKRakesh Kumar
Rakesh Kumar
AGArindam Ghosh
Arindam Ghosh
SASaba Annigeri
Saba Annigeri
JPJayant Prakash
Jayant Prakash
DJDipankar Jana
Dipankar Jana
Sepsis remains a leading cause of pediatric in-hospital mortality, particularly in resource-limited settings. The Pediatric Sequential Organ Failure Assessment (p-SOFA) score is widely used to guide prognostication, but its performance in children is suboptimal. The Phoenix Sepsis Score (PSS), developed specifically for pediatric patients, may offer improved predictive accuracy, yet validation data from Eastern India are lacking. We aimed to evaluate and compare the predictive performance of the PSS and p-SOFA scores for in-hospital mortality among children with sepsis admitted to a resource-limited pediatric intensive care unit (PICU) in Eastern India. This prospective analytical study enrolled children aged 1 month to 15 years with suspected or confirmed sepsis over 18 months. The PSS and p-SOFA scores were recorded on day 1 and day 3. Predictive performance for in-hospital mortality was assessed using the areas under the receiver-operating characteristic curve (AUROC), area under the precision–recall curve (AUPRC), sensitivity, specificity, positive predictive value, and negative predictive value. Multivariable logistic regression was used to estimate adjusted odds ratios (aOR) for mortality. Among 105 included children, 21 (20%) died during hospital stay. Non-survivors had significantly higher PSS and p-SOFA scores on both day 1 and day 3 (p < 0.001). On day 3, the PSS showed superior predictive performance (AUROC 0.910; AUPRC 0.678) compared to p-SOFA (AUROC 0.861; AUPRC 0.595). A PSS ≥5 on day 3 was associated with 96% sensitivity and significantly increased odds of in-hospital mortality (aOR 40.0, 95% CI: 35.1–47.5). Both scores are effective for mortality prediction, but the PSS demonstrated superior sensitivity, ease of use, and robustness in resource-limited environments. The PSS may serve as a more practical tool for early prognostication in pediatric sepsis. Kumar R, Ghosh A, Annigeri S, Prakash J, Jana D. Utility of Phoenix Sepsis Score for Predicting Mortality in Pediatric Sepsis: A Prospective Analytical Study from a Resource-limited Pediatric Intensive Care Unit in Eastern India. Indian J Crit Care Med 2026;30(1):27–34.

14 March 2026 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
PBPuja Bhagat
Puja Bhagat
RKRakesh Kumar
Rakesh Kumar
SASaba Annigeri
Saba Annigeri
AGArindam Ghosh
Arindam Ghosh
NKNiraj Kanaujia
Niraj Kanaujia
JPJayant Prakash
Jayant Prakash
Childhood cancers, though relatively uncommon, remain a leading cause of mortality and morbidity among children in low- and middle-income countries. Reliable epidemiological data from Eastern India, particularly from Bihar, remain limited. Despite the recent initiation of a population-based cancer registry (PBCR) in Bihar in 2018, its nonstatewide coverage hinders a comprehensive assessment of the disease burden and resource allocation for the entire region. To describe the incidence, spectrum, and demographic distribution of childhood tumors at a tertiary care center in Patna, Bihar, India, and to estimate the crude incidence rate (CIR) and age-standardized incidence rate (ASIR). A hospital-based cancer registry analysis was conducted at a tertiary care referral center in Patna, between January 2023 and September 2025. All newly diagnosed tumors in individuals aged 0 to 19 years (pediatric age group), confirmed histologically, cytologically, or by multidisciplinary consensus, were included. Malignancies were classified according to the International Classification of Childhood Cancer, third edition. Incidence rates were computed using the projected pediatric population of Patna, derived from the 2011 Census, and expressed as CIR and ASIR (per million person-years) with 95% confidence intervals (CI). Among 798 included patients, 756 (94.7%) had malignant and 42 (5.3%) benign tumors. The mean age at diagnosis was 7.5 ± 4.4 years, with a marked male predominance (M:F = 1.77:1). Solid malignancies (59.7%) outnumbered hematological malignancies (40.3%). The most common cancers were acute lymphoblastic leukemia (14.7%), Hodgkin lymphoma (13.4%), and retinoblastoma (11.4%). Among Patna-resident cases (n = 537), the CIR was 100.5 per million (95% CI: 93.2–107.8) and the ASIR was 106.5 per million. The highest age-specific incidence occurred in the <5-year group (29.8 per million). Embryonal tumors predominated in younger children, whereas lymphomas and bone sarcomas were more frequent among those aged 10 to <15 years. This hospital registry study at Patna reveals a substantial pediatric cancer burden, with a predominance of solid malignancies and a significant male excess. The observed high frequency of retinoblastoma and Hodgkin lymphoma, along with elevated CIR and ASIR values, underscores the urgent need for expanded PBCR coverage to accurately capture the disease burden and inform pediatric oncology planning in the region.